Nebivolol attenuates the anticonvulsant action of carbamazepine and phenobarbital against the maximal electroshock-induced seizures in mice
| Autor: | Monika Rudkowska, Kinga K. Borowicz-Reutt, Monika Banach |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Phenytoin
Memory Long-Term medicine.medical_treatment 030204 cardiovascular system & hematology Pharmacology Article Drug interactions Nebivolol Mice 03 medical and health sciences 0302 clinical medicine Pharmacotherapy Pharmacokinetics Seizures Electroshock maximal Animals Medicine Tissue Distribution Electroshock Dose-Response Relationship Drug business.industry Correction General Medicine Carbamazepine Motor coordination Disease Models Animal Anticonvulsant Adrenergic beta-1 Receptor Agonists Classical antiepileptic drugs Phenobarbital Anticonvulsants Female business 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Pharmacological Reports |
| ISSN: | 2299-5684 1734-1140 |
| DOI: | 10.1007/s43440-019-00029-6 |
| Popis: | Background Due to co-occurrence of seizures and cardiovascular disorders, nebivolol, a widely used selective β1-blocker with vasodilatory properties, may be co-administered with antiepileptic drugs. Therefore, we wanted to assess interactions between nebivolol and four conventional antiepileptic drugs: carbamazepine, valproate, phenytoin and phenobarbital in the screening model of tonic–clonic convulsions. Methods Seizure experiments were conducted in the electroconvulsive threshold and maximal electroshock tests in mice. The chimney test served as a method of assessing motor coordination, whereas long-term memory was evaluated in the computerized step-through passive-avoidance task. To exclude or confirm pharmacokinetic interactions, we measured brain concentrations of antiepileptic drugs using the fluorescence polarization immunoassay. Results It was shown that nebivolol applied at doses 0.5–15 mg/kg did not raise the threshold for electroconvulsions. However, nebivolol at the dose of 15 mg/kg reduced the anti-electroshock properties of carbamazepine. The effect of valproate, phenytoin, and phenobarbital remained unchanged by combination with the β-blocker. Nebivolol significantly decreased the brain concentration of valproate, but did not affect concentrations of remaining antiepileptic drugs. Therefore, contribution of pharmacokinetic interactions to the final effect of the nebivolol/carbamazepine combination seems not probable. Nebivolol alone and in combinations with antiepileptic drugs did not impair motor performance in mice. Nebivolol alone did not affect long-term memory of animals, and did not potentiate memory impairment induced by valproate and carbamazepine. Conclusions This study indicates that nebivolol attenuated effectiveness of some antiepileptic drugs. In case the results are confirmed in clinical settings, this β-blocker should be used with caution in epileptic patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink